The Welfare Consequences of Oncology Drug Shortages

肿瘤药物短缺的福利后果

• 批准号: 8601694
• 负责人: Mireille Jacobson
• 金额: $ 20.61万
• 依托单位: RAND CORPORATION
• 依托单位国家: 美国
• 财政年份: 2013
• 资助国家: 美国
• 起止时间: 2013-01-01 至 2015-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8601694
• 关键词: Accounting; Address; Affect; Age; Anesthesia procedures; Anti-Infective Agents; Attention; Breast; Cancer Patient; Case Study; Cessation of life; Chemotherapy-Oncologic Procedure; Clinical; Colorectal Cancer; Data; Databases; Diagnosis; Disease Progression; Dose; Doxorubicin; Drug Information Services; Drug Prescriptions; Event; Fluorouracil; Fostering; Generic Drugs; Goals; Government; Health; Healthcare; Hospitalization; Incidence; Individual; Injectable; Insurance Carriers; Life; Link; Literature; Longevity; Malignant Neoplasms; Malignant neoplasm of lung; Malignant neoplasm of ovary; Malignant neoplasm of pancreas; Manufacturer Name; Measures; Medical Errors; Medicare; Medicare claim; Names; Outcome; Paclitaxel; Paper; Patient Care; Patients; Pattern; Pharmaceutical Preparations; Policies; Price; Production; Provider; Registries; Reporting; SEER Program; Social Welfare; Sterility; Surveys; Time; Treatment Protocols; Treatment outcome; United States; Universities; Utah; Work; advanced disease; base; beneficiary; cancer care; cancer therapy; cancer type; chemotherapy; common treatment; cost; dosage; evidence base; expedited review; experience; manufacturing facility; mortality; oncology; patient population; payment; public health relevance

DESCRIPTION (provided by applicant): In this project we will estimate the welfare effects of oncology drug shortages on patients. In particular, we will study the effects of shortages on utilization of substitute drugs, treatment gaps, and dosage changes. In addition, we will analyze the effects on hospitalizations, disease progression, mortality and length of life as well as both out-of-pocket and total health care spending.

描述（由申请人提供）：在本项目中，我们将评估肿瘤药物短缺对患者的福利影响。特别是，我们将研究短缺对替代药物的利用，治疗差距和剂量变化的影响。此外，我们将分析对住院，疾病进展，死亡率和寿命以及自付和总医疗保健支出的影响。